RESEARCH NEWS 2014-09-18 Research News With predictions of a coming global avalanche of dementia cases, researchers are turning their attention to prevention strategies. Based on current data, at least four lifestyle factors robustly affect dementia risk, according to the World ...
PAPER Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R
Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging.Alzheimers Dement. 2005 Jul;1(1):11-8. PubMed: 19595811
RESEARCH NEWS 2014-09-18 Research News Some people seem to cope better than others with having amyloid plaques in their brains. According to a study in the September 14 Nature Neuroscience, they maintain cognitive prowess by kicking neural networks into overdrive. Such ...
PAPER Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ25217827
THERAPEUTICS AbbVie Small Molecule Other Alzheimer's Disease Phase 1 Breaking News ...
UCL Institute of OphthalmologyLondon, United Kingdom
PAPER Mitsis EM, Riggio S, Kostakoglu L, Dickstein DL, Machac J, Delman B, Goldstein M, Jennings D, D'Antonio E, Martin J, Naidich TP, Aloysi A, Fernandez C, Seibyl J, DeKosky ST, Elder GA, Marek K, Gordon W, Hof PR, Sano M, Gandy S
Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.Transl Psychiatry. 2014 Sep 16;4:e441. PubMed: 25226550
PAPER Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Kloszewska I, Soininen H, Mecocci P, Vellas B, Williams J, Stewart R, Sham P, Lovestone S, Powell JF
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis.PLoS Med. 2014 Sep;11(9):e1001713. Epub 2014 Sep 16 PubMed: 25226301
PAPER Vandenberghe R25224538
PAPER Brus B, Košak U, Turk S, Pišlar A, Coquelle N, Kos J, Stojan J, Colletier JP, Gobec S
Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor.J Med Chem. 2014 Sep 16; PubMed: 25226236
PAPER Soto M, Andrieu S, Nourhashemi F, Ousset PJ, Ballard C, Robert P, Vellas B, Lyketsos CG, Rosenberg PB
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Int Psychogeriatr. 2014 Sep 16;:1-17. PubMed: 25226218
PAPER Shahani N, Seshadri S, Jaaro-Peled H, Ishizuka K, Hirota-Tsuyada Y, Wang Q, Koga M, Sedlak TW, Korth C, Brandon NJ, Kamiya A, Subramaniam S, Tomoda T, Sawa A25224257
PAPER Saidlitz P, Voisin T, Vellas B, Payoux P, Gabelle A, Formaglio M, Delrieu J25226113
PAPER Fereshtehnejad SM, Lökk J25225618
No filters selected